Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ: COAG · Real-Time Price · USD

46.52

+1.52 (3.38%)

At close: Aug 4, 2026, 4:00 PM EDT

46.36

-0.16 (-0.34%)

After-hours: Aug 4, 2026, 7:34 PM EDT

COAG Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-70.12	-70.12	-50.38
Net Income	-63.91	-63.91	-48.71
Earnings Per Share	-67.56	-67.56	-51.49
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	163.53	185.49	88.33
Total Debt	1.06	1.22	1.73
Net Cash (Debt)	162.47	184.27	86.6
Net Cash Growth	87.61%	112.78%	-
Net Cash Per Share	171.74	194.78	91.54

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-61.48	-61.48	-45.59
Capital Expenditures	-0.02	-0.02	-0.28
Free Cash Flow	-61.49	-61.49	-45.87
Free Cash Flow Growth	-	-	-